2-chloro-n(6)cyclopentyladenosine has been researched along with isothiuronium in 1 studies
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (isothiuronium) | Trials (isothiuronium) | Recent Studies (post-2010) (isothiuronium) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 333 | 1 | 56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chelliah, J; Kukreja, RC; Levasseur, JE; Xi, L; Zhao, T | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and isothiuronium
| Article | Year |
|---|---|
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Topics: Adenosine; Animals; Enzyme Inhibitors; Female; Heart; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Ventricular Function, Left | 2000 |